BioMarin Pharmaceutical Inc. BMRN
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Akash Tewari | Wolfe Research | 58.23 $ | 95 $ | 36.77 % | 15/07/2025 |
| Olivia Brayer | Cantor Fitzgerald | 67 $ | 90 $ | 23.00 % | 30/10/2024 |
| Jack Allen | Robert W. Baird | 69.91 $ | 65 $ | -4.91 % | 30/10/2024 |
| David Lebowitz | Citigroup | 69.91 $ | 81 $ | 11.09 % | 30/10/2024 |
| Danielle Brill | Raymond James | 69.595 $ | 79 $ | 9.41 % | 10/10/2024 |
| Gena Wang | Barclays | 69.51 $ | 86 $ | 16.49 % | 04/10/2024 |
| David Lebowitz | Citigroup | 71.14 $ | 93 $ | 21.86 % | 18/09/2024 |
| George Farmer | Scotiabank | 71.21 $ | 78 $ | 6.79 % | 17/09/2024 |
| Joon Lee | Truist Financial | 71.205 $ | 90 $ | 18.80 % | 17/09/2024 |
| William Pickering | Bernstein | 69.86 $ | 90 $ | 20.14 % | 17/09/2024 |
| Kostas Biliouris | BMO Capital | 71.13 $ | 115 $ | 43.87 % | 17/09/2024 |
| Gena Wang | Barclays | 69.86 $ | 110 $ | 40.14 % | 16/09/2024 |
| Christopher Raymond | Raymond James | 86.74 $ | 122 $ | 35.26 % | 05/09/2024 |
| George Farmer | Scotiabank | 86.75 $ | 95 $ | 8.25 % | 05/09/2024 |
| Christopher Raymond | Raymond James | 88.69 $ | 107 $ | 18.31 % | 27/08/2024 |
| Paul Matteis | Stifel Nicolaus | 93.84 $ | 115 $ | 21.16 % | 21/08/2024 |
| William Pickering | Tudor Pickering | 94.2 $ | 110 $ | 15.80 % | 20/08/2024 |
| Paul Matteis | Stifel Nicolaus | 85.985 $ | 112 $ | 26.02 % | 06/08/2024 |
| Cory Kasimov | Evercore ISI | 85.985 $ | 115 $ | 29.02 % | 06/08/2024 |
| Whitney Ijem | Canaccord Genuity | 80.47 $ | 93 $ | 12.53 % | 06/08/2024 |
| Mohit Bansal | Wells Fargo | 85.25 $ | 115 $ | 29.75 % | 27/06/2024 |
| William Pickering | Tudor Pickering | 78.87 $ | 91 $ | 12.13 % | 04/06/2024 |
| Jack Allen | Robert W. Baird | 76.97 $ | 72 $ | -4.97 % | 17/05/2024 |
| Cory Kasimov | Evercore ISI | 80.5 $ | 113 $ | 32.50 % | 13/05/2024 |
| George Farmer | Scotiabank | 91.2 $ | 85 $ | -6.20 % | 25/04/2024 |
| Eliana Merle | UBS | 89.49 $ | 119 $ | 29.51 % | 22/04/2024 |
| Kostas Biliouris | BMO Capital | 85.89 $ | 102 $ | 16.11 % | 05/07/2023 |
| Christopher Raymond | Raymond James | 92.1 $ | 128 $ | 35.90 % | 26/10/2022 |
| Robyn Karnauskas | Truist Financial | 89.41 $ | 133 $ | 43.59 % | 12/09/2022 |
| Olivia Brayer | Cantor Fitzgerald | 87.85 $ | 110 $ | 22.15 % | 12/07/2022 |
| Matthew Harrison | Morgan Stanley | 80.5 $ | 113 $ | 32.50 % | 25/04/2022 |
| Joshua Schimmer | Evercore ISI | 85.37 $ | 105 $ | 19.63 % | 22/02/2022 |
| Matthew Harrison | Morgan Stanley | 84.86 $ | 90 $ | 5.14 % | 18/02/2022 |
| Geoff Meacham | Bank of America Securities | 84.39 $ | 120 $ | 35.61 % | 10/01/2022 |
| Phil Nadeau | Cowen & Co. | 88.38 $ | 135 $ | 46.62 % | 08/12/2021 |
| Tiago Fauth | Credit Suisse | 90.3 $ | 105 $ | 14.70 % | 22/11/2021 |
| Debjit Chattopadhyay | Guggenheim | 91.47 $ | 120 $ | 28.53 % | 19/11/2021 |